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Abstract
Objective. There are no vaccines for most of the major invasive
Salmonella strains causing severe infection in humans. We
evaluated the specificity of adaptive T memory cell responses
generated after Salmonella Typhi exposure in humans against
other major invasive Salmonella strains sharing capacity for
dissemination. Methods. T memory cells from eleven volunteers
who underwent controlled oral challenge with wt S. Typhi were
characterised by flow cytometry for cross-reactive cellular cytokine/
chemokine effector responses or evidence of degranulation upon
stimulation with autologous B-lymphoblastoid cells infected with
either S. Typhi, Salmonella Paratyphi A (PA), S. Paratyphi B (PB) or
an invasive nontyphoidal Salmonella strain of the S. Typhimurium
serovar (iNTSTy). Results. Blood T-cell effector memory (TEM)
responses after exposure to S. Typhi in humans evolve late, peaking
weeks after infection in most volunteers. Induced multifunctional
CD4+ Th1 and CD8+ TEM cells elicited after S. Typhi challenge were
cross-reactive with PA, PB and iNTSTy. The magnitude of
multifunctional CD4+ TEM cell responses to S. Typhi correlated with
induction of cross-reactive multifunctional CD8+ TEM cells against PA,
PB and iNTSTy. Highly multifunctional subsets and T central memory
and T effector memory cells that re-express CD45 (TEMRA)
demonstrated less heterologous T-cell cross-reactivity, and
multifunctional Th17 elicited after S. Typhi challenge was not cross-
reactive against other invasive Salmonella. Conclusion. Gaps in cross-
reactive immune effector functions in human T-cell memory
compartments were highly dependent on invasive Salmonella strain,
underscoring the importance of strain-dependent vaccination in the
design of T-cell-based vaccines for invasive Salmonella.
ª 2020 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of
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INTRODUCTION
Invasive Salmonella infection, caused by typhoidal
Salmonella (most commonly S. Typhi or
S. Paratyphi A) or invasive nontyphoidal
Salmonella (iNTS), is spread by faecal–oral route
and is responsible for millions of infections yearly
and over 600 000 deaths annually, with most
mortality caused by iNTS.1–3 There are no vaccines
in clinical use known to prevent disease from
S. Paratyphi A (PA) or iNTS. Dominant Salmonella
Typhimurium and S. Enteriditis iNTS strains
evolving within the last 60 years, identified in
sub-Saharan Africa, have significant genomic
changes associated with invasive disease absent
from typical nontyphoidal Salmonella (NTS) strains
producing localised gastroenteritis.4–6 iNTS
disease, often presenting with bacteraemia and
focal infection such as meningitis or pneumonia,
is associated with a case fatality rate of over 20%
and is seen in young children with risk factors
such as malnutrition and anaemia, or in the
setting of co-infections with malaria or HIV.7,8
Three serovars, S. Typhi, PA and S. Paratyphi B
(PB), are the predominant causes of enteric fever
(typhoid and paratyphoid disease) globally, and
genomic differences between typhoidal serovars
are underscored by studies demonstrating their
convergent evolution.9–11 PA incidence is rapidly
increasing in South-East Asia, and an epidemic of
extensively drug-resistant S. Typhi is ongoing in
South Asia since 2016.12–14 Given high incidence
of invasive Salmonella infection, low-sensitivity
diagnostics and high rates of antimicrobial use for
suspected infection, antimicrobial resistance
against invasive Salmonella is increasing.12,13,15–18
Improving vaccination against all major invasive
Salmonella by preventing severe and fatal
infections would counteract the threat posed by
emerging antibiotic-resistant strains of Salmonella
and decrease mortality associated with these
infections.
While there are data that invasive Salmonella
host defence in humans involves antibody
production,19 the importance of T-cell-dependent
host defence mechanisms against these
intracellular bacteria is supported by studies
demonstrating increased human susceptibility to
invasive Salmonella disease in the presence of
specific STAT4 or HLA II polymorphisms or
disruptions in IL-12 or IL-23 signalling pathways in
humans.20–22 Murine models of invasive
Salmonella infection additionally demonstrate a
critical role for T cells in host defence.23 Studies in
a human challenge model in which volunteers
were orally challenged with wild-type S. Typhi
demonstrate that high baseline frequencies of
multifunctional CD8+ TEM cell responses correlated
with protection from the development of typhoid
disease.24 Salmonella Typhi vaccines administered
in humans generate CD8+ T cells with the capacity
to kill Salmonella-infected cells in vitro, with
killing function correlating with expression of
CD8+ T-cell IFN-c production.25–27 HIV infection
and decreased CD4+ T-cell counts correlate with
susceptibility to invasive nontyphoidal Salmonella
infection rather than disease with typhoidal
strains.28 These observations demonstrate that the
characteristics of human T-cell responses and the
genetics of the Salmonella strain fundamentally
impact risk of invasive Salmonella infection in
humans.
There are three vaccines currently in clinical use
against S. Typhi, but two of these are based on
the Vi capsular polysaccharide found in S. Typhi
and absent in other major prevalent invasive
Salmonella strains. The live-attenuated Ty21a
vaccine (generated from an S. Typhi strain by
nondirected mutagenesis) does not confer cross-
protection against PA disease,29 but was
moderately protective against PB.30 After human
Ty21a vaccination, low frequencies of highly
multifunctional PA cross-reactive peripheral CD8+
T cells are elicited compared to frequencies of
reactive CD8+ T cells against S. Typhi.31 It is
unknown whether wild-type S. Typhi contains
antigens able to elicit both cross-reactive CD4+
and CD8+ T-cell effector functions against other
major invasive Salmonella for which vaccines are
lacking, such as iNTS strains and PA, or how
biologic differences between different invasive
Salmonella strains impact T-cell priming and the
development of T-cell memory and effector
functions in humans.
Mice inherently resist mucosal and systemic
infection with S. Typhi and develop systemic
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infection with Salmonella strains that typically
cause only local gastroenteritis in humans. Given
that host species and Salmonella strain are
important in host susceptibility to disease and
disease pathogenesis, we sought to evaluate
elements of T-cell cross-reactivity in humans
against invasive Salmonella. The human challenge
model directs acquisition of infection through
oral–mucosal exposure and characterisation of
systemic memory immune responses in individuals
longitudinally, without previous history of
invasive Salmonella infection. Here, in a
controlled human oral challenge model of
S. Typhi infection, we dissect the cross-reactive
immune effector functions of induced memory T
cells within different human memory T-cell
subsets, against PA, PB and an S. Typhimurium
isolated in Mali of the ST313 multilocus sequence
type (iNTSTy), as a representative iNTS of serovar
Typhimurium circulating in sub-Saharan Africa.
RESULTS
Volunteers (n = 11) developed typhoid disease
approximately 9 days after oral wt S. Typhi
challenge. On average, volunteers exhibited classic
clinical features of acute systemic S. Typhi
infection such as decreases in platelets and serum
haemoglobin, as summarised in Supplementary
table 1. At the time of typhoid diagnosis,
volunteers immediately started a 2-week curative
antibiotic regimen for S. Typhi infection.
Peripheral blood mononuclear cells (PBMCs)
collected from volunteers prior to challenge (day
0), and at days 14, 21, 28 and 60 after challenge,
were stimulated with autologous B-LCL infected
with S. Typhi. Frequencies of activated CD8+ T
effector memory cells (CD8+ TEM, CD 69
+/CD62L/
CD45RA) were analysed for expression of CD107a
or IFN-c production. Net responses were subtracted
from responses to uninfected B-LCL at all
timepoints to determine the peak response per
cytokine or effector function. Eight of 11
volunteers had peak IFN-c effector responses
28 days or later after challenge, and 7 of 11
volunteers had peak frequencies of S. Typhi-
reactive CD8+ TEM cell CD107a expression (a
degranulation marker) 28 days or later after
challenge (Figure 1a and c). Activated CD4+ TEM cell
responses (CD4+ TEM, CD69
+/CD62L-/CD45RA-) were
also evaluated following stimulation with S. Typhi-
infected autologous B-LCL for individual
frequencies of IFN-c, TNF-a or IL-17A expression
(Figure 1b, d and e). For these cell subsets as well,
most volunteers develop a peak response for these
individual effector functions 28 days or later after
challenge, occurring in 9 of 11 volunteers for
activated CD4+ TEM cells expressing IFN-c. Peak
blood CD4+ and CD8+ T-cell responses after S. Typhi
challenge occurred long after the diagnosis of
typhoid disease and after completion of antibiotic
treatment in most volunteers (Figure 1).
We next assessed for the presence of cross-
reactive T-cell responses against other invasive
Salmonella elicited after S. Typhi challenge. PBMCs
from individual volunteers collected prior to or at
various timepoints after challenge were stimulated
with autologous B-LCL-infected with either
S. Typhi (ST), S. Paratyphi A (PA), S. Paratyphi B
(PB) or S. Typhimurium iNTS with the ST313
genotype (sub-Saharan African iNTS, iNTSTy). A
representative volunteer’s CD4+ TEM and CD8
+ TEM
cell effector responses (expression of TNF-a, IFN-c,
IL-2, MIP-1b, IL-17A or surface CD107a expression)
are shown over time against four different
invasive Salmonella strains, as measured following
stimulation of B-LCL-infected targets
(Supplementary figure 1). For each of the 11
volunteers, the timepoint of the peak of the CD8+
TEM cells IFN-c response was identified against ST
(ST peak). At ST peak, CD8+ TEM cells were
evaluated for simultaneous expression of two or
more effector functions upon stimulation with B-
LCL infected with either PA, PB or iNTSTy.
Volunteers demonstrated an induced CD8+ TEM cell
cross-reactive response, with high frequencies of
multifunctional CD8+ TEM cells with two or more
concomitant effector functions against typhoidal
and invasive nontyphoidal Salmonella (Figure 2a,
c, e and g). When these same CD8+ TEM cells were
evaluated for reactivity against PA, PB or iNTSTy
with 3 or more concomitant effector functions, we
observed that while there was an induced cross-
reactive response against PB, there were limited
induced cross-reactive responses against PA or
iNTSTy (Figure 2b, d, f and h). These data suggest
that while multifunctional cross-reactive CD8+ TEM
cells are induced against other invasive Salmonella
after oral S. Typhi challenge in humans, highly
multifunctional CD8+ TEM subset responses occur
only against S. Typhi and S. Paratyphi B.
Given the strong correlation of human CD8+ T-
cell production of IFN-c against Salmonella-
infected cells and human in vitro cytolytic activity
of Salmonella-infected cells,26 we assessed the
hypothesis that CD8+TEM cells induced after
ª 2020 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of
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Figure 1. Late development of peak peripheral blood T-cell effector memory responses in humans orally challenged with wt Salmonella Typhi.
CD8+ TEM or CD4
+ TEM cells from individual volunteers were evaluated for CD107a expression, and production of IFN-c, TNF-a or IL-17A upon
stimulation with autologous S. Typhi (ST)-infected target cells on days 0, 14, 21, 28 and 60 days after challenge. Background responses from
uninfected targets were subtracted. The timepoint of highest effector responses per volunteer (n = 11) per effector function was determined for
(a) CD8+/CD69+/IFN-c+ TEM cells, (b) CD8
+/CD69+/CD107a+ TEM cells, (c) CD4
+/CD69+/IFN-c+ TEM cells, (d) CD4
+/CD69+/TNF-a+ TEM cells or (e)
CD4+/CD69+/IL-17A+ TEM cells. Each measurement was performed once per volunteer per effector function. TD: typhoid disease, red bar
indicating range of days observed in volunteers for time of TD diagnosis. Volunteers initiated a curative antibiotic course at the time of TD
diagnosis.
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S. Typhi challenge predominate in IFN-c+
multifunctional subsets. To this end, we measured
frequencies of CD8+ TEM cells expressing IFN-c
alone, that is, not simultaneously expressing any
of the other measured effector functions (TNF-a,
IL-2, MIP-1b, IL-17A or surface CD107a). At the
d
0
S
T
 p
e
a
k
0
5
1 0
1 5
2 0
2 5
C
D
8
+
 T
E
M
 (
%
)
            p = 0 .0 4 7
d
0
S
T
 p
e
a
k
0
5
1 0
1 5
2 0
2 5
3 0
C
D
8
+
 T
E
M
 (
%
)
            p = 0 .0 3
(e)
(g)
d
0
S
T
 p
e
a
k
0
5
1 0
1 5
2 0
C
D
8
+
 T
E
M
 (
%
)
            p = 0 .0 8
iNTSTy
d
0
S
T
 p
e
a
k
0
5
1 0
1 5
2 0
2 5
C
D
8
+
 T
E
M
 (
%
)             p = 0 .0 3 6
d
0
S
T
 p
e
a
k
0
2
4
6
8
1 0
C
D
8
+
 T
E
M
 (
%
)
            p = 0 .0 0 5 5
d
0
S
T
 p
e
a
k
0
5
1 0
1 5
C
D
8
+
 T
E
M
(%
)
            p = 0 .0 0 1 2
d
0
S
T
 p
e
a
k
0
5
1 0
1 5
2 0
C
D
8
+
T
E
M
 (
%
)
            p = 0 .0 4
d
0
S
T
 p
e
a
k
0
5
1 0
1 5
C
D
8
+
 T
E
M
 (
%
)
            p = 0 .1 2
PB
ST
PA
(c)
(b)(a)
(h)
(f)
2+ Effector functions 3+ Effector functions
(d)
Figure 2. Oral wt Salmonella Typhi challenge in humans induces multifunctional CD8+ TEM cells that are cross-reactive with other Salmonella
serovars. PBMCs from individual volunteers collected prior to (d0) and at the peak of the total CD8+ TEM IFN-c response after S. Typhi challenge
(ST peak) were stimulated with targets infected with either ST (a, b), PA (c, d), PB (e, f) or iNTSTy (g, h). CD8+ TEM cells were analysed for
simultaneous expression of the following effector functions (production of TNF-a, IL-17A, IFN-c, MIP-1b, IL-2 and/or expression of CD107a).
Frequencies of reactive multifunctional CD69+ CD8+ TEM cells with at least two concomitant effector functions (a, c, e, g); and multifunctional
CD69+ CD8+ TEM cells exhibiting at least three concomitant effector functions (b, d, f, h). n = 11 volunteers for a–f, n = 8 volunteers for g and
h. Paired responses from each volunteer are indicated by lines, and one measurement was performed for each volunteer per timepoint. Data
were analysed by a paired Student’s t-test; P-values are displayed.
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peak of the CD8+ TEM cell response against
S. Typhi, although a trend was apparent, we
found that CD8+ TEM cells expressing only IFN-c
were not significantly induced after oral challenge
(Figure 3a). In addition, there was no significantly
induced cross-reactive response of cells with this
phenotype against other typhoidal or invasive
nontyphoidal Salmonella strains (Figure 3b–d).
In contrast, high frequencies of CD8+ TEM cells
simultaneously producing IFN-c and TNF-a, and
expressing the degranulation marker CD107a, with
or without simultaneous expression of MIP-1b, were
induced following S. Typhi challenge. These
induced responses were significantly cross-reactive
against PA and PB, but not against the more
genetically distant iNTSTy (Figure 4a). Of note, this
multifunctional CD8+ TEM population induced by
human S. Typhi challenge is of higher magnitude
than the induced CD8+ TEMRA population, identified
as CD62L/CD45RA+ (Figure 4b). The CD8+ TEMRA
population is notable for re-expression of CD45RA
and is a more highly differentiated human T
memory cell population, with lower proliferative
capacity, than CD8+ TEM cells. We have previously
shown that multifunctional S. Typhi-specific CD8+
TEMRA cells are induced after Ty21a vaccination
31
and also after human oral S. Typhi challenge,24
albeit at lower frequencies than those observed in
the CD8+ TEM population. Here, we observed
significant increases in the frequencies of this
population against ST, but no significant induction
of cross-reactive CD8+ TEMRA cells with the IFN-c
+/
TNF-a+/CD107a+/MIP-1b+/ phenotype against PA,
PB or iNTS. (Figure 4b). Hence, this multifunctional
CD8+ TEMRA subset elicited after human oral S. Typhi
challenge is induced at lower frequencies and is
iNTSTy
d
0
S
T
 p
e
a
k
0 .0
0 .5
1 .0
1 .5
2 .0
IF
N
 (
%
) p = 0 .0 6
d
0
S
T
 p
e
a
k
0
1
2
3
4
IF
N
 (
%
)
p = 0 .2 3
d
0
S
T
 p
e
a
k
0
1
2
3
4
IF
N
 (
%
) p = 0 .1 3
d
0
S
T
 p
e
a
k
0
1
2
3
4
IF
N
 (
%
) p = 0 .2 2
(d)
PB
(a)
(c)
(b)
CD8+ TEM single positive IFN
ST PA
Figure 3. Lack of induction of serovar cross-reactive CD8+ TEM cells producing IFN-c in the absence of simultaneous production of either TNF-a,
MIP-1b, IL-17A, IL-2 or surface expression of CD107a in the blood of Salmonella Typhi-challenged volunteers. PBMCs from S. Typhi-challenged
participants were stimulated with target cells infected with either (a) ST, (b) PA, (c) PB or (d) iNTSTy. Boolean gating was performed on
CD69+CD8+ TEM cells to evaluate individual cell expression of IFN-c in the absence of other cytokines above or expression of CD107a in individual
cells. Frequencies are shown for CD8+ TEM cells prior to challenge (d0) and at the peak of the CD8
+ TEM cell IFN-c response (ST peak). n = 11
volunteers for a–c, n = 8 volunteers for d. Paired responses are indicated by lines, and one measurement was performed for each volunteer per
timepoint. Data were analysed by a paired Student’s t-test; P-values are displayed.
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minimally cross-reactive with other invasive
Salmonella.
The TCM population (CD62L
+, CD45RA) is
classically associated with homing to central
lymphoid organs, with high proliferative potential
and functional IL-2 expression, supporting growth,
expansion and survival of antigen-specific memory
T cells. We observed that CD8+ TCM and CD4
+ TCM
cells elicited after S. Typhi challenge are induced
against S. Typhi and cross-reactive only with PA
(Figure 5a and b). Notably, there were no
significant induced TCM responses cross-reactive
against PB and iNTSTy.
Given the magnitude of the induced CD8+ TEM
subset after human S. Typhi challenge, and the
identification of cross-reactive multifunctional IFN-
c+ CD8+TEM, we examined the relationship of pre-
existing frequencies of IFN-c+ CD8+ TEM reactive
against different invasive Salmonella strains to
peak IFN-c+ CD8+ TEM responses after human
S. Typhi challenge. We observed that ST, PA and
iNTSTy all had strong correlations in magnitude of
frequencies of IFN-c+ CD8+ TEM cells at baseline
with the magnitude of the peak of the IFN-c+
CD8+ TEM cell response against the respective
invasive strain after oral S. Typhi challenge
(Figure 6a–c), suggesting that S. Typhi challenge
expands baseline reactive CD8+ T cells as part of
the response to infection. Baseline IFN-c+ CD8+
TEM cell reactivity to ST also correlated with the
peak magnitude of the IFN-c+ CD8+ TEM cell
response against PA (Figure 6d). Notably,
however, there was no correlation between
baseline IFN-c+ CD8+ TEM cell responses to ST and
the peak magnitude of the IFN-c+ CD8+ TEM cell
iNTSTy response (Figure 6e) after S. Typhi
challenge, indicating that volunteers with low or
high IFN-c+ CD8+ TEM cell baseline frequencies
against ST did not have a predictable IFN-c+ CD8+
TEM cell peak response against iNTSTy. This
pattern suggests that a proportion of the cross-
reactive responses that are elicited after human
oral S. Typhi challenge and that are reactive
against iNTSTy are not expanded from the pre-
existing repertoire of CD8+ TEM cells reactive to ST,
underscoring differences in the properties of the
cross-reactive T-cell responses to iNTSTy and PA.
We evaluated whether expression of the gut
mucosal-associated homing integrin a4b7 differed
among the multifunctional Salmonella cross-
reactive peripheral CD8+ TEM subsets observed
after oral S. Typhi challenge, as evaluated at the
peak of the blood CD8+TEM cell IFN-c response
against ST. We observed no differences in the
frequencies of integrin a4b7 expression among
CD8+ TEM cells expressing two or more, or three or
more concomitant functions, among the different
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Figure 4. Induction of multifunctional, serovar cross-reactive blood
CD8+ TEM cells, but not CD8
+ TEMRA cells that simultaneously produce
IFN-c and TNF-a and express CD107a, with or without MIP-1b
production, after Salmonella Typhi challenge. PBMCs prior to infection
(d0) and at the timepoint of peak total peripheral CD69+ CD8+ TEM cell
IFN-c response after S. Typhi challenge in each volunteer (ST peak), were
stimulated with autologous targets infected with either ST, PA, PB or
iNTSTy. CD69+ CD8+ TEM cells (a) or CD69
+ CD8+ TEMRA cells (b) were
analysed for simultaneous expression of 6 effector functions (production
of TNF-a, IL-17, IFN-c, MIP-1b, IL-2 and/or expression of CD107a).
Mean  SEM and individual responses are shown. n = 11 volunteers for
ST, PA and PB reactivity, n = 8 volunteers for iNTSTy reactivity. One
measurement was performed per volunteer. Data were analysed by a
paired Student’s t-test; P-values are displayed.
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invasive Salmonella (Supplementary figure 2).
Additionally, there were no differences in cross-
reactive frequencies of CD8+ TEM cells containing
simultaneous effector functions of IFN-c+/TNF-a+/
CD107a+/MIP-1b+/ that also expressed integrin
a4b7 (Supplementary figure 2). Hence, while the
expression of a4b7 was noted in only a subset of
the reactive multifunctional CD8+ TEM cells, there
was no difference in frequencies among
multifunctional subsets induced after human oral
S. Typhi challenge, and no significant differences
in frequencies of a4b7 multifunctional CD8
+ TEM
cell cross-reactive with PA, PB or iNTSTy.
We also assessed whether serovar cross-reactive
multifunctional CD4+ T cells secreting IFN-c (Th1)
or IL-17A (Th17) cells are elicited after human oral
S. Typhi challenge. High frequencies of
multifunctional CD4+ TEM cells, concomitantly
expressing at least IFN-c and one or more
additional effector functions, were elicited after
oral wt S. Typhi challenge, as assessed at the peak
of the total IFN-c CD4+ TEM cell response against
ST, and these responses were similarly cross-
reactive against PA, PB and iNTSTy (Figure 7a, c, e
and g). Notably, at the peak of the CD4+ TEM cell
IFN-c response there were no significantly induced
multifunctional Th17 responses against any of the
invasive Salmonella strains (Figure 7b, d, f and h).
More individuals had a peak peripheral blood
CD4+ TEM cell IL-17A response at earlier timepoints
after oral S. Typhi challenge than those observed
for the peak peripheral blood CD4+ TEM cell IFN-c
response (Figure 1b and e). When we measured
multifunctional Th17 induction at the peak of the
Th17 response against ST (ST IL-17A peak), we
observed that significant frequencies of
multifunctional Th17 with reactivity against ST
were induced (Figure 7i). Interestingly, these
lower magnitude peripheral multifunctional Th17
responses elicited after oral wt S. Typhi challenge
were not significantly cross-reactive against PA, PB
or iNTSTy (Figure 7j–l).
Multiple studies have demonstrated that CD4+ T
cells are required for the generation of optimal
CD8+ T-cell memory cell responses and that
repeated antigenic stimulation does not substitute
for CD4+ T-cell help when priming CD8+ T-cell
memory responses.32 Given the sizable frequencies
of multifunctional serovar cross-reactive Th1
elicited after human oral S. Typhi challenge in the
peripheral blood, we examined the hypothesis
that robust induced multifunctional CD4+ Th1
responses against ST correlates with peak
multifunctional CD8+TEM responses against ST and
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Figure 5. Increased frequencies of TCM cells expressing IL-2 that are cross-reactive with Salmonella Paratyphi A after Salmonella Typhi challenge.
PBMCs prior to infection (d0) or at the timepoint of peak total peripheral CD8+ TEM or CD4
+ TEM IFN-c responses after S. Typhi challenge per
individual volunteer (ST peak) were stimulated with targets infected with either ST, PA, PB, or iNTSTy. CD69+ CD4+ TCM (a) and CD69
+ CD8+ TCM
(b) cells were assessed for intracellular IL-2 expression. n = 11 volunteers assessed for ST, PA and PB reactivity, n = 8 volunteers assessed for
iNTSTy reactivity. One measurement was performed per volunteer. Mean  SEM and individual responses are shown. Data were analysed by a
paired Student’s t-test; P-values are displayed.
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other invasive Salmonella. We observed that while
there was a moderate positive relationship
between the peak IFN-c+ CD4+ TEM cell response
against ST and the multifunctional CD8+ TEM cell
response (P = 0.061), this relation was not
statistically significant (Figure 8a). However, we
observed that the induced CD4+ TEM cell response
against ST correlated strongly with the
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Figure 6. The magnitude of Salmonella Typhi baseline CD8+ TEM cell IFN-c responses correlates with the magnitude of peak CD8
+ TEM cell IFN-c
responses against S. Typhi and Salmonella Paratyphi A but not iNTSTy. PBMCs obtained prior to and after oral S. Typhi challenge at days 14, 21,
28 or 60 were stimulated with targets infected with either ST, PA, PB or iNTSTy. Individual peak CD8+ TEM cell IFN-c responses postchallenge
were determined for each serovar and are plotted against the corresponding baseline CD8+ TEM cell IFN-c reactivity. Shown are baseline to peak
CD8+ TEM cell IFN-c reactivity for ST (a), iNTSTy (b) and S. Paratyphi A (c). Individual volunteer paired reactivity measurements are plotted, n = 11
for a and c, and n = 8 for b. (d) Correlation of baseline ST CD8+ TEM cell IFN-c responses to peak CD8
+ TEM cell IFN-c responses to PA (paired
responses, n = 11) (e) Correlation of baseline ST CD8+ TEM cell IFN-c to peak CD8
+ TEM cell IFN-c responses to iNTSTy (paired responses, n = 8).
r, R2, and P-values are presented.
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(a)
ST
PA
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iNTSTy
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(c) (d) (j)
(e) (f) (k)
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(l)
Figure 7. Differential kinetics, magnitude and frequencies of multifunctional, serovar cross-reactive CD4+ Th1 and CD4+ Th17 effector memory
cells in peripheral blood after human oral wt Salmonella Typhi challenge. PBMCs collected from volunteers prior to S. Typhi challenge (d0) or at
the timepoint of peak blood total CD4+ TEM IFN-c responses after S. Typhi challenge (ST peak) or peak peripheral CD4
+ TEM IL-17A responses (ST
peak IL-17A) were stimulated with targets infected with either ST (a, b, i), PA (c, d, j), PB (e, f, k) or iNTSTy (g–i). CD69+ CD4+ TEM cells were
analysed for simultaneous expression of six effector functions (production of TNF-a, IL-17A, IFN-c, MIP-1b, IL-2 and/or expression of CD107a).
Multifunctional Th1 or Th17 cells were defined as expressing IFN-c (Th1) or IL-17A (Th17) and at least one other additional effector function.
Multifunctional CD69+/IFN-c+ CD4+ TEM (a, c, e, g) or CD69
+/IL-17A+ CD4+ TEM (b, d, f, h) cells were evaluated at the peak of the total CD4
+
TEM cell IFN-c response. Multifunctional CD69
+/IL-17A CD4+ TEM cells were also evaluated at the peak of the total CD4
+ TEM cell IL-17A response
(i–l). n = 11 volunteers assessed for ST, PA and PB reactivity, n = 8 volunteers assessed for iNTSTy reactivity. Paired responses are indicated by
lines. One measurement per volunteer was made per timepoint. Data were analysed by a paired Student’s t-test; P-values are displayed.
2020 | Vol. 9 | e1178
Page 10
ª 2020 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of
Australian and New Zealand Society for Immunology, Inc.
Heterologous T cell memory for invasive Salmonella RR Rapaka et al.
cross-reactive multifunctional CD8+ TEM cell
response against PA, PB and iNTSTy (Figure 8b–d).
These data suggest a relationship between the
induction of robust Th1 responses after S. Typhi
challenge and the induction of high frequencies
of cross-reactive multifunctional CD8+ TEM cells
against invasive Salmonella strains in humans.
DISCUSSION
There are no vaccines in clinical use against
S. Paratyphi or iNTS infection, despite significant
disease burden and mortality. Phylogenetic
studies show S. Typhi more closely related to PA
than to iNTS S. Typhimurium strains.7 Biologic
differences between iNTS S. Typhimurium and NTS
S. Typhimurium impact antigen-presenting cell
migration in murine infection and human
macrophage inflammatory and antibacterial
cytotoxic responses.33,34 Virulence factors, such as
the Vi capsule, are present in S. Typhi but absent
in PA and iNTS strains, and attachment pili differ
considerably among serovars.35 In a murine model
of invasive Salmonella vaccination, effective host
memory defence responses were serovar-
dependent and LPS-independent after oral
challenge with different nontyphoidal Salmonella
serovars.36 Recent studies have shown that very
minor serovar differences in Salmonella
immunodominant antigens PhoN and CdtB impact
CD4+ T-cell cross-reactivity from T-cell clones
expanded after human wt S. Typhi challenge.37
Given genetic and phenotypic differences
between Salmonella strains, the present study
evaluates the development and functional
specificity of adaptive heterologous T-cell memory
(a) (b)
(c) (d)
Figure 8. Induction of multifunctional Th1 against Salmonella Typhi after human oral challenge correlates with the induction of multifunctional
serovar cross-reactive CD8+ TEM cells. PBMCs from individual volunteers at the peak of the total peripheral CD4
+ TEM IFN-c response were
analysed for the frequencies of IFN-c+CD4+ TEM cells with at least one or more concomitant additional effector functions (either CD107a
expression or TNF-a, MIP-1b, IL-17A or IL-2 production) against ST and plotted against the frequencies of CD8+ TEM cells, as evaluated at the
peak of total peripheral CD8+ TEM cell IFN-c response per volunteer, with at least 2 or more effector functions (production of TNF-a, MIP-1b, IL-2,
IL-17A and/or expression of CD107a) against either ST (a), PA (b), PB (c) or iNTSTy (d). Eleven volunteers were studied in a–c and 8 volunteers in
d. Single paired measurements were made for each volunteer and plotted. Responses of individual volunteers are shown with correlation
coefficient (r), coefficient of determination (R2) and P-value.
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responses in humans against genetically distinct
Salmonella sharing capacity for mucosal invasion
and dissemination. Our methods emphasise
assessment of T-cell functionality upon exposure
to antigen-presenting cells infected with ST, PA,
PB or iNTSTy, without selective expansion of
memory cell clones, and on the characterisation of
both human CD4+ and CD8+ T-cell memory
compartments induced after experimental oral wt
S. Typhi challenge.
Among individuals orally challenged with wt
S. Typhi and developing typhoid disease, we
observed that the peripheral blood T-cell response
continues to evolve in most volunteers long after
antibiotic treatment, with generation of peak
peripheral blood CD4+ and CD8+ TEM cells with
different effector functions by 1 month or later
postchallenge in most volunteers. The observation
of peak peripheral human T memory cell
responses occurring several weeks after clinical
symptoms of typhoid disease contrasts with
studies of different human viral mucosal
infections, where elicitation of peripheral blood T
cells with an effector memory phenotype peaks
1 week after development of symptoms in
hantavirus infection38 or 1 week after intranasal
challenge with influenza.39 In contrast to a variety
of human viral infections, where systemic T-cell
responses appear much earlier in the clinical
course of infection, the evolution of peripheral
blood T-cell effector memory responses against
S. Typhi has a delayed kinetics.40,41 One
explanation for the observed delayed TEM
presence in the blood after S. Typhi challenge
may be the result of TEM cells migrating to
mucosal sites initially during early infection and
therefore present at reduced levels in circulation
soon after infection. Alternately, the delayed
peripheral blood T memory cell response may be
consistent with early immune evasion mechanisms
operative in invasive S. Typhi infection, whereby
particular S. Typhi gene products impair antigen
presentation to T cells42,43 or impair recognition
or inflammatory pathways by antigen-presenting
cells or mucosal tissues.44,45 Attenuated S. Typhi
vaccine Ty21a is currently administered as multiple
doses of vaccine over a 1-week period. Our
observation of a delayed T-cell effector response
after S. Typhi challenge may support the benefit
of a late timepoint booster immunisation for
next-generation live-attenuated S. Typhi
vaccination, after the peripheral memory T-cell
pool has matured in response to infection in
humans, to potentially extend the duration of
long-lived immunity.
Multifunctional T-cell responses are associated
with superior immune protection in human
infection with viruses46–49 and intracellular
bacteria and parasites.50–52 We have previously
shown that individuals who resist development of
typhoid disease after S. Typhi challenge have
significantly increased frequencies of S. Typhi-
reactive multifunctional CD8+ T cells in peripheral
blood prior to challenge relative to those who
develop typhoid disease.24 These baseline T-cell
memory frequencies observed in individuals with
no prior history of prior S. Typhi exposure or
vaccination may be the result of exposure to
other cross-reactive Enterobacteriaceae or cross-
reactive environmental antigens.53 Here, we
observed that high frequencies of multifunctional
CD8+ T effector memory cells with two or more
concomitant effector functions are induced after
S. Typhi challenge and are highly cross-reactive
with PA, PB, as well as iNTSTy-infected targets.
Significant induction of highly multifunctional
CD8+ T effector memory cells with three or more
effector functions, however, was only observed
against PB-infected targets. This observation
suggests that the heterologous CD8+ T-cell
responses induced in humans after S. Typhi
challenge may involve a signal threshold for
multifunctional responses that are not achieved
from exposure to PA or iNTSTy-infected targets.
One hypothesis for why this may occur is that
antigens presented by PA or iNTSTy-infected
targets may not interact as strongly with CD8+ T-
cell receptors, subsequently impacting
downstream signalling and cytokine production,
resulting in cross-reactive T cells with fewer
measured effector functions. Alternately, the
immunodominant antigens or their peptide
sequences may significantly differ between PA, PB
and iNTSTy, leading to different frequencies of
multifunctional CD8+ T-cell responses. These
studies are the first to demonstrate that
multifunctional CD8+ TEM cells produced after
human wt S. Typhi exposure produces
significantly induced cross-reactive responses
against PA, PB and iNTSTy, yet the functional
characteristics of the CD8+ TEM cell response are
impacted, at least in part, by serovar.
Human CD8+ T-cell cytolytic activity against
S. Typhi-infected targets, induced after Ty21a
vaccination, is MHC I-dependent25 and is very highly
correlated with frequencies of IFN-c producing
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S. Typhi-specific CD8+ T cells.26 In a murine model of
vaccination against invasive Salmonella, CD8+ T cells
and IFN-c signalling were important in recall host
defence mechanisms on challenge with S.
Typhimurium, impacting survival.54 Here, we
demonstrate that the IFN-c producing CD8+ TEM cells
induced after human S. Typhi infection is primarily
multifunctional, as we observed no significant
induction of CD8+ TEM IFN-c monofunctional cells.
Additionally, there was no observed induced
response by cross-reactive CD8+ T effector memory
single positive IFN-c-producing cells against other
invasive Salmonella strains. Hence, human
challenge with S. Typhi leads to the induction of
multifunctional serovar cross-reactive IFN-c+ CD8+ T
effector memory cells, given our observation of
significantly induced CD8+ TEM cells with the IFN-c
+/
TNF-a+/CD107a+/MIP-1b+/ phenotype. Since IFN-c
monofunctional T cells contrast significantly at the
level of transcription from IFN-c multifunctional
cells as observed in different human infections,55
our data suggest after human infection with
S. Typhi, there is preferential induction of
multifunctional CD8+ TEM cells within the memory
compartment, and only multifunctional IFN-c+CD8+
TEM cell responses are significantly cross-reactive.
A specific population of CD8+ TEM cells with
simultaneous evidence of degranulation (as
measured by CD107a expression) and production
of IFN-c and TNF-a, with or without production of
MIP-1b, was highly induced after human S. Typhi
challenge. This multifunctional population with 3
or more specific effectors was highly cross-reactive
with PA and PB but not iNTSTy. In contrast,
human Ty21a vaccination led to the development
of multifunctional CD8+ TEM cells expressing IFN-c
and CD107a without TNF-a expression that were
cross-reactive against PB but not against PA.31
These data suggest that genetic changes in Ty21a,
which lead to phenotypic changes including its
attenuation and absence of Vi capsule for
example, impact aspects of human antigen
presentation and CD8+ T-cell memory
programming and that wt S. Typhi infection
promotes a more robust cross-reactive CD8+ T-cell
response against PA. In contrast to cross-reactivity
observed against PA after human S. Typhi
challenge, this cross-reactivity is markedly
decreased when assessed against targets infected
with the more genetically distant iNTSTy. Genetic
and phenotypic differences between Ty21a and
wt S. Typhi may account for the more limited
CD8+ T-cell cross-reactive responses against PA
observed after Ty21a vaccination. Our findings
underscore the potential for reengineering
S. Typhi-based oral vaccines to obtain optimal
cross-reactive CD8+ T-cell responses against PA in
vaccination.
We observed strong correlations between
frequencies of S. Typhi-specific IFN-c+ CD8+ TEM
cells prior to challenge and the magnitude of the
peak S. Typhi-specific IFN-c+ CD8+ TEM cell
response after challenge. This observation
suggests that part of the immune response to
infection involves expansion of baseline T-cell
memory responses from the pre-existing
repertoire in individuals with no history of prior
S. Typhi infection or vaccination. We also
observed a correlation in PA and iNTSTy baseline
IFN-c+ CD8+ TEM cell responses to peak responses,
suggesting that the pre-existing IFN-c+ CD8+ TEM
cell repertoire reactive to these genetically distant
invasive Salmonella are expanded by S. Typhi
challenge. Interestingly, the relationship between
baseline S. Typhi-specific IFN-c+ CD8+ TEM cell
responses and peak PA IFN-c+ CD8+ TEM cell
responses also highly correlates, while the
relationship to peak iNTS IFN-c+ CD8+ TEM cell
responses does not. These data suggest that
baseline CD8+ T-cell reactivity with iNTS
corresponds predominantly to different CD8+ T-
cell antigen specificities, which are expanded after
S. Typhi challenge, and that dominant CD8+ T-cell
antigens are different between iNTSTy and
S. Typhi. These findings support observations by
Napolitani et al., where more cross-reactive T-cell
clones and the antigens they react with were
shared between S. Typhi and PA rather than iNTS
S. Typhimurium.37 Alternately, IFN-c+ CD8+ T cells
induced by S. Typhi challenge may have
differential activation to iNTS antigens compared
to typhoidal serovars, secondary to potential
differences in antigen presentation.
CD8+ TEM cells induced after S. Typhi challenge
expressing two or more effector functions, three
or more effector functions, or the CD107a+/TNF-a+/
IFN-c+/MIP-1b+/ phenotype, did not differ in
expression of gut-homing molecule integrin a4b7
upon exposure to antigen-presenting cells
infected with either S. Typhi, PA, PB or iNTSTy.
These data suggest that multifunctional, serovar
cross-reactive CD8+ TEM cells generated after
human S. Typhi challenge have similar potential
for homing to gut mucosal tissues. That a high
proportion of these induced multifunctional CD8+
T cells do not express integrin a4b7 supports
ª 2020 The Authors. Clinical & Translational Immunology published by John Wiley & Sons Australia, Ltd on behalf of
Australian and New Zealand Society for Immunology, Inc.
2020 | Vol. 9 | e1178
Page 13
RR Rapaka et al. Heterologous T cell memory for invasive Salmonella
similar data we have previously reported in
volunteers immunised with attenuated S. Typhi
vaccines.31,56,57 These results underscore the
increased presence in circulation of memory T
cells elicited in S. Typhi-challenged adults with the
ability to home to mucosal and other systemic
tissues, which may prevent dissemination during
future Salmonella infections.
We observed significant differences among
memory T-cell compartments with regard to T-cell
serovar cross-reactivity. Salmonella Typhi
challenge induced CD4+ and CD8+ TCM producing
IL-2, but only, surprisingly, demonstrating
significant cross-reactivity against PA and not
against iNTSTy- or PB-infected targets. In some
models of infection with intracellular bacteria or
parasites, the TCM population plays an essential
role in host defence.58,59 Thus, the absence of
cross-reactivity against iNTSTy or PB may impact
vaccine design. In addition, after wt S. Typhi
challenge, multifunctional CD8+ TEMRA cells,
terminally differentiated effector memory cells
implicated in protection mechanisms in viral
infections such as HIV and influenza,60,61 were not
significantly cross-reactive against PA, PB or
iNTSTy. The clinical significance of the absence of
heterologous T-cell responses within these
memory compartments is unclear, but
demonstrates that T-cell memory subset
reactivation is specifically and differentially
impacted by serovar, potentially through
differences in bacterial phenotype during
infection of antigen-presenting cells, or through
specific differences in antigens between serovars,
leading to differential T-cell subset cross-reactivity.
We show that the predominant multifunctional
CD4+ TEM cell response in human blood after
S. Typhi challenge is a Th1 response, rather than a
Th17 response. The induced multifunctional Th1
response is notably cross-reactive against PA, PB
and iNTSTy. In contrast, while a multifunctional
induced Th17 response occurs against S. Typhi
after challenge, this response is generally of lower
magnitude than the Th1 response and is notably
not cross-reactive against iNTSTy, PA or PB. The
role of Th17 immunity specifically in human host
defence against S. Typhi or other typical invasive
Salmonella strains is unclear. Studies with a
nontyphoidal S. Typhimurium strain in a SIV-
infected macaque model of infection showed
importance of Th17 responses in limiting bacterial
dissemination from the gut mucosa.62 In a cohort
of Bangladeshi patients with natural S. Typhi
infection, T cells reactive with S. Typhi antigens
were found to express IFN-c early after
developing S. Typhi bacteraemia, while T cells
producing IL-17 reactive with S. Typhi antigens
were only observed in significant numbers 2–
4 weeks after bacteraemia development.63 Human
immunisation with Ty21a generates IL-17A-
producing CD4+ T cells at the terminal ileum
mucosa, as well as CD8+ T cells producing IL-17A
at the mucosa and in the blood.64–66 The
dominance of multifunctional CD4+ Th1 effector
memory elicited in the blood in humans after oral
S. Typhi challenge is consistent with findings
demonstrating a prominent IFN transcriptional
response in humans infected with S. Typhi67,68
and may impact on the diversity of IFN-c-
dependent cytolytic mechanisms against
Salmonella.69
We demonstrate that the magnitude of
multifunctional IFN-c CD4+ TEM cell response to
S. Typhi correlates with induction of cross-reactive
multifunctional CD8+ TEM cells in humans.
Expansion and maintenance of memory CD8+ T
cells are CD4+ T-cell-dependent in numerous
infection models,32,70–73 with data supporting an
essential role of CD4+ T cells in aspects of initial
memory CD8+ T-cell priming through factors such
as CD27 and CD40 signalling.74,75 We have
previously shown that humans challenged with
S. Typhi exhibited enhanced CD8+ TEM cell
responses in vitro when T regulatory cells are
depleted during the process of stimulation with
S. Typhi-infected antigen-presenting cells.76 Given
that a major risk factor in humans for invasive
Salmonella infection, particularly with the
nontyphoidal serovars, is HIV infection and CD4+
T-cell deficiency, these data underscore one
mechanism whereby CD4+ T-cell responses could
impact a critical effector mechanism against
invasive Salmonella infection in humans.
These data further the hypothesis that CD4+ T
cells enhance immunity to invasive Salmonella in
humans, at least in part, through priming memory
CD8+ T-cell responses and/or enhancing their
activation upon secondary exposure to invasive
Salmonella antigens. We show here that
heightened multifunctional CD4+ T-cell IFN-c
responses after S. Typhi challenge correlate
specifically with heterologous, serovar-
independent CD8+ T-cell multifunctional responses
upon secondary stimulation with invasive
Salmonella antigens, pointing to the capability of
S. Typhi in generating heterologous
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multifunctional CD4+ and CD8+ T-cell responses in
humans. Collectively, these data suggest that
S. Typhi, as a parent strain for a vaccine for iNTS
or S. Paratyphi strains, induces cross-reactive
multifunctional effector memory CD4+ T and CD8+
T-cell responses. However, significant gaps in
cross-reactive immune responses are noted in T-
cell memory compartments and by specific cellular
functionalities, dependent on invasive Salmonella
strain, demonstrating that ultimately genetic
differences between strains impact memory T-cell
recognition, activation and signalling against
invasive Salmonella-infected cells. Particularly for
iNTS, these data underscore the importance of
strain-specific vaccination to prevent invasive
Salmonella infection in humans.
METHODS
Participants and human challenge model
Data were collected from clinical samples obtained from a
human challenge model of typhoid fever (UKCRN ID 9297;
approval: Oxfordshire Research Ethics Committee A [10/
H604/53], as previously described by Waddington et al.77
Male or female volunteers, healthy, between ages 18 and
60, were recruited by the Oxford Vaccine Group, and
written informed consent was obtained for participation.
Individuals were excluded from the study if they had a
history of prior S. Typhi vaccination and prior typhoid
disease, or had resided in an S. Typhi endemic area for
more than 6 months. Volunteers underwent challenge with
a single oral dose of ~ 1.98 9 104 CFU [range (1.5 9 104–
2.69 9 104)] wild-type S. Typhi (Quailes strain), suspended
in sodium bicarbonate solution, administered after 90 min
of fasting. The challenge study was conducted in an
ambulatory setting with daily blood culture and daily
surveillance for safety, clinical measurements and laboratory
measurements. Participants received a two-week course of
antibiotics (oral ciprofloxacin) starting immediately at time
of diagnosis of typhoid disease (TD) or by 14 days after
challenge. TD was defined as either (1) one or more
positive blood cultures collected after day 5 postchallenge
or (2) sustained fever observed after challenge
(temperature above 38°C lasting 12 or more hours). PBMCs
from 11 participants who developed TD were randomly
selected for further characterisation of memory T-cell
immune responses. A summary of demographic and clinical
parameters of participants whose samples were used in this
study is provided in Supplementary table 1; these
parameters are similar to those observed in the broader
study cohort as previously described.77
Preparation of effector cells
Peripheral blood mononuclear cells were separated by
gradient centrifugation and cryopreserved in liquid
nitrogen within 4 h of blood draw. On thawing, cell
viability was assessed by trypan blue exclusion. Cells were
rested overnight at 37°C, 5% CO2 in RPMI containing 100 U
mL1 penicillin, 100 µg mL1 streptomycin, 50 µg mL1
gentamicin, 1 mM L-glutamine, 10 mM HEPES buffer and
10% heat-inactivated foetal bovine serum, prior to
presentation to infected stimulator cells.
Preparation of stimulator cells and
Salmonella infection of stimulator cells
Autologous Epstein–Barr virus (EBV)-transformed B-
lymphoblastoid cell lines (B-LCL) were generated from
PBMCs from individual volunteers, to ultimately serve as
stimulator cells, as previously described.78 Salmonella strains
were obtained from University of Maryland-CVD reference
stocks: S. Typhi strain ISP-1820 (a clinical isolate from Chile,
Vi+), S. Paratyphi A strain CV 223 (ATCC #9150, Manassas,
VA, USA) and S. Paratyphi B strain CV 23 (a clinical isolate
from Chile), and the S. Typhimurium invasive nontyphoidal
strain D65, with the ST313 genotype (a clinical isolate from
a bacteraemic child in Mali79). B-LCL cells were infected
with individual Salmonella strains (at a 10:1 bacteria:B-LCL
cell ratio) in RPMI without antibiotics. Infection proceeded
for 3 h, after which time cells were washed in cRPMI, and
incubated overnight in the presence of 150 µg mL1
gentamicin. To confirm B-LCL infection with Salmonella
strains, infected B-LCL were stained with FITC-conjugated
antibody against Salmonella common structural Ag (CSA-1,
Kierkegaard & Perry, Gaithersburg, MD, USA) and analysed
by flow cytometry.
Ex vivo stimulation of effector cells
B-LCL-infected stimulator cells were gamma-irradiated
(6000 rad) and co-cultured with PBMCs. PBMCs cultured
without target cells and with uninfected target cells were
used as negative controls, and PBMCs cultured in the
presence of Staphylococcal enterotoxin B (SEB) at
10 µg mL1 served as a positive control. Ex vivo stimulation
proceeded in the presence of FITC-conjugated anti-CD107a
(BD Biosciences, San Jose, CA, USA). After 2 h, monensin
(1 µg mL1) and Brefeldin A (2 µg mL1) were added to
cocultures. Cells were incubated overnight and harvested
for immunostaining.
Surface and Intracellular staining, and
gating protocol
Peripheral blood mononuclear cells were stained for live/
dead discrimination using yellow fluorescent viability dye
(YEVID, Invitrogen, Carlsbad, CA, USA) and then washed
with buffer (PBS with 2% FCS), and nonspecific Fc receptor
binding was blocked by incubation with human
immunoglobulin (3 µg mL1; Sigma-Aldrich, St. Louis, MO,
USA) for 20 min at room temperature. Cells were then
stained extracellularly and intracellularly with a panel of
fluorochrome-conjugated monoclonal antibodies as
previously described.24 Cells were fixed in 1%
paraformaldehyde and stored at 4°C until analysis. Flow
cytometry was performed using an LSRII flow cytometer
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(BD), and during sample acquisition, between 300 000 and
500 000 events were collected per sample. Data were
analysed using WinList version 9.0 (Verity Software House,
Topsham, ME, USA). Singlet CD3+ CD4+ T cells or CD3+
CD8+ T cells and T memory subsets were evaluated for
expression of CD45RA and CD62L for determination of T
central memory (TCM; CD62L
+ CD45RA), T effector memory
(TEM; CD62L
CD45RA) and T effector memory CD45 RA+
(TEMRA; CD62L
 CD45 RA+) subsets. Na€ıve T cells (TN) were
defined as CD62L+ CD45RA+. The FCOM analysis tool was
used to characterise events based on selected gate
combinations in multidimensional space to determine
multifunctional subsets. Flow cytometry experiments were
performed at the Flow Cytometry and Mass Cytometry
Core Facility of the University of Maryland School of
Medicine Center for Innovative Biomedical Resources
(CIBR).
Statistics
All statistical tests were performed with GraphPad Prism 6.0
software (GraphPad Prism, La Jolla, CA, USA). Comparisons
between two groups were performed with a paired
Student’s t-test. Pearson’s correlations were calculated
assuming bivariate Gaussian distributions among variables,
and linear regression lines were fit to the data with 95%
confidence bands. Statistical significance was accepted for
P < 0.05.
Study approval
In obtaining the clinical samples used in this study, written
informed consent was obtained, and the clinical protocol
was approved by National Research Ethics Service,
Oxfordshire Research Ethics Committee A (10/H0604/53).
The clinical study proceeded in accordance with the
International Conference on Harmonisation Good Clinical
Practice Guidelines.
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